{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1b\/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody\u00ae-CD3 X CD20) in Relapsed\/Refractory Chronic Lymphocytic Leukemia","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1b-2-open-label-safety-and-efficacy-study-of-epcoritamab-gen3013-duobody-cd3-x-cd20-in-relapsed-refractory-chronic-lymphocytic-leukemia\/#breadcrumbitem"}]}